This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

4 Stocks Under $10 Making Big Moves

Ventrus Biosciences

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Ventrus Biosciences (VTUS) is a specialty pharmaceutical company focused on the development and commercialization of late-stage prescription drugs for gastrointestinal disorders, specifically hemorrhoids, anal fissures and fecal incontinence. This stock is trading up 5.3% to $4.01 in recent trading.

Today's Range: $3.77-$4.04

52-Week Range: $3.46-$13.53

Volume: 72,000

Three-Month Average Volume: 303,604

Shares of VTUS are moving sharply higher today in front of its upcoming presentation at the Stifel Nicolaus 2012 Healthcare Conference today and at the UBS Global Life Sciences Conference on Sept. 20.

>>5 Stocks Set to Soar on Bullish Earnings From a technical perspective, VTUS is starting to move back above its 50-day moving average of $3.85 here with light volume. This move is coming after VTUS gapped down huge in June from over $12 to below $5 with monster volume. Following that plunge, shares of VTUS went on to hit a low of $3.46, and then trended sideways between $3.55 and $4.14 for two months. Shares of VTUS are now quickly moving into range of triggering a near-term breakout trade. That trade will hit once VTUS clears some near-term overhead resistance at $4.15 to $4.40 with high volume.

Traders should now look for long-biased trades in VTUS as long as its trending above its 50-day, and then once it sustains a move or close above $4.15 to $4.40 with volume that's near or above 303,604 shares. If that breakout triggers soon, then VTUS will have a great chance of hitting $5 to $6 in the near future.
4 of 5

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
DVR $0.01 0.00%
ODP $5.86 0.51%
VTUS $16.49 -1.02%
AAPL $95.18 1.64%
FB $117.43 -0.96%


Chart of I:DJI
DOW 17,750.91 -140.25 -0.78%
S&P 500 2,063.37 -18.06 -0.87%
NASDAQ 4,763.2240 -54.37 -1.13%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs